Post by Stanford Beckman Center

Congratulations to Beckman Center's Paul Bollyky on leading Stanford's new Center for Phage Pharmaceuticals, supported by a $9.5 million grant from the National Institute of Allergy and Infectious Diseases. The center will advance bacteriophage therapies to help combat antibiotic resistant infections, driving innovative research with the potential to improve patient care. 🔗 https://lnkd.in/e3ugCWue 📸 Kolpona/Adobe Stock #Stanford #BeckmanCenter #PhageTherapy